Suzhou Highfine Biotech Co., Ltd.(XSEC:301393) added to S&P Global BMI Index
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.45 CNY | +2.76% | -2.32% | -29.26% |
05-13 | Suzhou Highfine Biotech Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
04-25 | Suzhou Highfine Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.26% | 614M | |
+5.69% | 103B | |
-11.38% | 60.26B | |
+67.14% | 45.41B | |
+12.80% | 38.25B | |
+0.91% | 31.37B | |
+10.29% | 16.64B | |
+7.82% | 13.86B | |
-5.51% | 12.84B | |
-24.66% | 12.43B |
- Stock Market
- Equities
- 301393 Stock
- News Suzhou Highfine Biotech Co., Ltd.
- Suzhou Highfine Biotech Co., Ltd.(XSEC: 301393) added to S&P Global BMI Index